February 23, 2018 / 2:59 PM / 8 months ago

BRIEF-Swedish Orphan Biovitrum says receives positive opinion from CHMP on Anakira

Feb 23 (Reuters) - Swedish Orphan Biovitrum Ab (Publ) says:

* The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for Anakinra for the treatment of Still’s disease.

* The opinion is now referred to the European Commission for a decision. Source text for Eikon: Further company coverage: (Reporting By Johan Sennero)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below